News

EXCITING NEWS

Featured Articles

February 9, 2021
The McQuade Center for Strategic Research and Development and Eikonizo Therapeutics Enter Agreement to Develop Treatments for Patients with Rare Diseases
businesswire a berkshire
August 12, 2020
Meet the 21 biotech startups that top VCs say are poised to take off in the next 12 months (Subscription Required)
bi company text
July 08, 2020
Eikonizo Therapeutics Announces Publication of the First-in-Human Study of [18F]EKZ-001 and Expansion of Leadership Team, Adding Extensive Experience in Preclinical and Clinical Development
businesswire a berkshire
February 9, 2021
The McQuade Center for Strategic Research and Development and Eikonizo Therapeutics Enter Agreement to Develop Treatments for Patients with Rare Diseases
businesswire a berkshire
August 12, 2020
Meet the 21 biotech startups that top VCs say are poised to take off in the next 12 months (Subscription Required)
bi company text
July 08, 2020
Eikonizo Therapeutics Announces Publication of the First-in-Human Study of [18F]EKZ-001 and Expansion of Leadership Team, Adding Extensive Experience in Preclinical and Clinical Development
businesswire a berkshire
June 25, 2020
Episode 59: Using Tau to Target Alzheimer’s
pharmexec cropped company
June 25, 2020
Episode 59: Using Tau to Target Alzheimer’s
pharmexec cropped company
June 2, 2020
UNDER THE MICROSCOPE: LUDO VAN DEN BOSCH ON RETURNING TO WORK, EXPLORING THERAPEUTIC STRATEGIES TO BATTLE ALS & FTD
target als green
May 5, 2020
TARGET ALS AND AFTD ANNOUNCE $5MM IN GRANTS FOR RESEARCH TARGETING TREATMENTS AND BIOMARKERS
target als green
June 2, 2020
UNDER THE MICROSCOPE: LUDO VAN DEN BOSCH ON RETURNING TO WORK, EXPLORING THERAPEUTIC STRATEGIES TO BATTLE ALS & FTD
target als green
May 5, 2020
TARGET ALS AND AFTD ANNOUNCE $5MM IN GRANTS FOR RESEARCH TARGETING TREATMENTS AND BIOMARKERS
target als green
April 1, 2020
Making Progress On A Micro-Budget
life science leader
April 1, 2020
Making Progress On A Micro-Budget
life science leader

Earlier Articles

March 20, 2020
Eikonizo: brain-penetrant HDAC inhibitors for neurodegeneration (Subscription Required)
biocentury logo dark
March 10, 2020
Women of the C-Suite: “Your career path might not always be linear,” With Janice Kranz, PhD of Eikonizo Therapeutics
authority magazine stylized
March 4, 2020
Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer's And Other Dementia
cision orange and
March 20, 2020
Eikonizo: brain-penetrant HDAC inhibitors for neurodegeneration(Subscription Required)
biocentury logo dark
March 10, 2020
Women of the C-Suite: “Your career path might not always be linear,” With Janice Kranz, PhD of Eikonizo Therapeutics
authority magazine stylized
March 4, 2020
Nearly $4 Million In Research Funding For Promising New Treatments In Alzheimer's And Other Dementia
cision orange and
December 30, 2019
Mass. Biotech Sector Feels Drug Pricing Pressure
wbur yellow circular
December 30, 2019
Mass. Biotech Sector Feels Drug Pricing Pressure
wbur yellow circular
December 9, 2019
Untangling tau protein (Subscription Required)
c and i company
October 23, 2019
New Approaches to Alzheimer’s and Tauopathies: Eikonizo Therapeutics
biospace logo and
December 9, 2019
Untangling tau protein (Subscription Required)
c and i company
October 23, 2019
New Approaches to Alzheimer’s and Tauopathies: Eikonizo Therapeutics
biospace logo and
September 24, 2019
Dementia-Treatment Startup Seeks to Overcome Prior Drugs’ Failures (Subscription Required)
wall street journal
September 24, 2019
Dementia-Treatment Startup Seeks to Overcome Prior Drugs’ Failures (Subscription Required)
wall street journal